Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...